Modafinil: A Review of Neurochemical Actions and Effects on Cognition
The DOI matches its Crossref record; 215 of the 215 references it cites were found in a registry or an index.
Abstract
Modafinil (2-[(Diphenylmethyl) sulfinyl] acetamide, Provigil) is an FDA-approved medication with wake-promoting properties. Pre-clinical studies of modafinil suggest a complex profile of neurochemical and behavioral effects, distinct from those of amphetamine. In addition, modafinil shows initial promise for a variety of off-label indications in psychiatry, including treatment-resistant depression, attention-deficit/hyperactivity disorder, and schizophrenia. Cognitive dysfunction may be a particularly important emerging treatment target for modafinil, across these and other neuropsychiatric disorders. We aimed to comprehensively review the empirical literature on neurochemical actions of modafinil, and effects on cognition in animal models, healthy adult humans, and clinical populations. We searched PubMed with the search term 'modafinil' and reviewed all English-language articles for neurochemical, neurophysiological, cognitive, or information-processing experimental measures. We additionally summarized the pharmacokinetic profile of modafinil and clinical efficacy in psychiatric patients. Modafinil exhibits robust effects on catecholamines, serotonin, glutamate, gamma amino-butyric acid, orexin, and histamine systems in the brain. Many of these effects may be secondary to catecholamine effects, with some selectivity for cortical over subcortical sites of action. In addition, modafinil (at well-tolerated doses) improves function in several cognitive domains, including workin…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, side effects of alpha agonists like guanfacine and clonidine include high prevalence of somnolence or sedating effects,168,169”
From Report of a Work Group on Sluggish Cognitive Tempo: Key Research Directions and a Consensus Change in Terminology to Cognitive Disengagement Syndrome (2023) · cites this paper as [168]
In the citing paper
“Modafinil, which is approved by the US Food and Drug Administration for the treatment of narcolepsy and its associated daytime sleepiness [59], is a logical candidate to address the hypoactive/sleepy aspects of CDS.”
Citations
Cites
Items 201–215 of 215
Rambert, F. A., Pessonnier, J., & Duteil, J. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)93344-p · Cited by 25 · cited 1×
“…mg/kg i.p. m Activity blocked by prazosin or reserpine, not by sulpiride or aMPT m Activity blocked by sulpiride or aMPT, not by prazosin or reserpine Rambert et al, 1993 Methylphenidate 16–64 mg/kg i.p. m Activity blocked by sulpiride or resperine, not by prazosin or aMPT Locomotor activity…”
BackgroundDetection of modafinil in human urine by gas chromatography–mass spectrometry
Tseng, Y. L., Uralets, V., Lin, C., & Kuo, F.-H. (2005) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2005.04.050 · Cited by 25 · cited 2×
“In addition, modafinil shows initial promise for a variety of off-label indications in psychiatry, including treatment-resistant depression, attention- deficit/hyperactivity disorder, and schizophrenia.”
BackgroundLonger Auditory and Visual P300 Latencies in Patients with Narcolepsy
Sangal, R. B., Sangal, J. M., & Belisle, C. (1999) · Clinical Electroencephalography · doi:10.1177/155005949903000111 · Cited by 22 · cited 1×
“…0, 200, 400 mg p.o. Clinical responders: k latency auditory and visual P300 and m amplitude auditory and visual P300 RT on auditory, visual tasks Sangal et al, 1999b Wisconsin card sort test Narcolepsy patients 24 400 mg p.o. qd or 300 mg p.o. bid, vs placebo, for 3 weeks; double-blind k…”
BackgroundKrazem, A., Béracochéa, D., & Jaffard, R. (1995) · Behavioural Brain Research · doi:10.1016/0166-4328(94)00103-m · Cited by 22 · cited 1×
“…to use current cues to rapidly adopt a context-appropriate strategy to make correct responses, and this learning curve is sensitive to damage to either the anterior cingulate (but not posterior cingulate) cortex or the mediodorsal nucleus of the thalamus (Krazem et al, 1995; Meunier et al, 1991).”
BackgroundHellriegel, E. T., Arora, S., Nelson, M., & Robertson, P. (2002) · The Journal of Clinical Pharmacology · doi:10.1177/00912700222011382 · Cited by 22 · cited 2×
“Neuropsychopharmacology (2008) 33, 1477–1502; doi:10.1038/sj.npp.1301534; published online 22 August 2007 Keywords: modafinil; dopamine; norepinephrine; cognition; psychiatry”
BackgroundInfluentialHellriegel, E. T., Arora, S., Nelson, M., & Robertson, P. (2001) · The Journal of Clinical Pharmacology · doi:10.1177/00912700122010690 · Cited by 21 · cited 2×
“Neuropsychopharmacology (2008) 33, 1477–1502; doi:10.1038/sj.npp.1301534; published online 22 August 2007 Keywords: modafinil; dopamine; norepinephrine; cognition; psychiatry”
BackgroundInfluentialTanganelli, S., Ferraro, L., Bianchi, C., & Fuxé, K. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90639-4 · Cited by 20 · cited 6×
“…et al, 2007 k cortical GABA by modafinil abolished in 6-OHDAlesioned animals 30 mg/kg s.c. for 7 d Intracranial microdialysis Guinea pig Tanganelli et al, 1994 Prevents loss of DA or non-DA neurons in SN after MPTP 100 mg/kg i.p. Tyr-Hydroxylase-IR C57bl/6 mouse Aguirre et al,…”
BackgroundInfluentialModafinil-Induced Irritability and Aggression?
Ranjan, S., & Chandra, P. S. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000185346.77966.a4 · Cited by 19 · cited 1×
“Whereas other single case reports have appeared describing adverse events in the treatment of psychiatric patients such as clozapine toxicity (Dequardo, 2002), premature ventricular contractions (Oskooilar, 2005), induced mania (Vorspan et al, 2005; Wolf et al, 2006), and irritability and verbal aggression (Ranjan and…”
ResultStress-induced subsensitivity to modafinil and its prevention by corticosteroids
Stone, E. A., Lin, Y., Suckow, R. F., & Quartermain, D. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00962-0 · Cited by 17 · cited 4×
“…affinity for a2 receptors (Hieble et al, 1995)) or phenoxybenzamine diminishes modafinil-induced increases in arousal (Lin et al, 1992) and activity in rats and monkeys (Duteil et al, 1990; Hermant et al, 1991), as does terazosin pre-treatment or a1B receptor knockouts in mice (Stone et al, 2002a).”
BackgroundInfluentialInfluence of modafinil on somatosensory input processing in the human brain-stem
Marca, G. D., Restuccia, D., Rubino, M., Maiese, T., & Tonali, P. (2003) · Clinical Neurophysiology · doi:10.1016/j.clinph.2003.11.003 · Cited by 13 · cited 1×
“…ms latency burst) over frontal, central and parietal areas; source-localized to subcortical 2nd burst (18–28 ms latency) 500–700 Hz oscillations Della Marca et al, 2004 CANTAB and other cognitive tasks Healthy adults 60 0, 100, 200 mg p.o. parallel groups kRT Stroop color-naming, m accuracy…”
BackgroundFerraro, L., Tanganelli, S., Fuxé, K., Bebe, B. W., Tomasini, M. C., Rambert, F. A., & Antonelli, T. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02000-5 · Cited by 13 · cited 2×
“…addition, in frontal cortical slices, modafinil increases electrically evoked (but not spontaneous) 5HT efflux in a concentration-dependent manner (Ferraro et al, 2000, 2001), whereas neither type of 5HT efflux is affected by modafinil in cortical synaptosomes, in contrast to fenfluramine, which…”
ResultVisual P300 latency predicts treatment response to modafinil in patients with narcolepsy
Sangal, R. B., Sangal, J. M., & Belisle, C. (1999) · Clinical Neurophysiology · doi:10.1016/s1388-2457(99)00035-8 · Cited by 12 · cited 1×
“…0, 200, 400 mg p.o. Clinical responders: k latency auditory and visual P300 and m amplitude auditory and visual P300 RT on auditory, visual tasks Sangal et al, 1999b Wisconsin card sort test Narcolepsy patients 24 400 mg p.o. qd or 300 mg p.o. bid, vs placebo, for 3 weeks; double-blind k…”
BackgroundA Case of Premature Ventricular Contractions With Modafinil
Oskooilar, N. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.10.1983-a · Cited by 10 · cited 1×
“Whereas other single case reports have appeared describing adverse events in the treatment of psychiatric patients such as clozapine toxicity (Dequardo, 2002), premature ventricular contractions (Oskooilar, 2005), induced mania (Vorspan et al, 2005; Wolf et al, 2006), and irritability and verbal aggression (Ranjan and…”
ResultEffect of modafinil on cerebral blood flow of anaesthetised rats
Florence, G., Bonnier, R., Plagnes, D., Pi�rard, C., Satabin, P., Pérès, M., & Lagarde, D. (2000) · Experimental Brain Research · doi:10.1007/s002210000555 · Cited by 10 · cited 3×
“No effect on CBF m CBF Florence et al, 2000 Heart rate, mean arterial blood pressure Smaller m HR (vs AMP); no change MABP Larger m HR (vs Modafinil); m MABP Locomotor activity Mouse 20–40 mg/kg i.p. Amphetamine 2–4 mg/kg i.p. m Activity similar to AMP m Activity Simon et al, 1994 M o d a fin il n e u ro c h e m istry…”
BackgroundInfluentialCiliax (1999) · doi:10.1002/(sici)1096-9861(19990621)409:1<38::aid-cne4>3.0.co;2-1 · cited 1×
“In post-mortem human brains, DAT is found not only in the striatum, but also throughout the neocortex, including the PFC, albeit at relatively lower concentrations (Ciliax et al, 1999).”
Background
Research works printed but not linked: 1
- Wong YN, Simcoe D, Hartman LN, Laughton WB, King SP, McCormick GC et al (1999b). A double-blind, placebo-controlled, ascending-dose evaluation of the pharmacokinetics and tolerability of modafinil tablets in healthy male volunteers. J Clin Pharmacol 39: 30–40. · DOI · Paper page
Cited by
Inhibition and impulsivity: behavioral and neural basis of response control
Bari, A., & Robbins, T. W. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.06.005 · Cited by 1,921
Towards responsible use of cognitive-enhancing drugs by the healthy
Greely, H., Sahakian, B., Harris, J., Kessler, R. C., Gazzaniga, M., Campbell, P., & Farah, M. J. (2008) · Nature · doi:10.1038/456702a · Cited by 862
del Campo, N., Chamberlain, S. R., Sahakian, B. J., & Robbins, T. W. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.02.036 · Cited by 685
Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review
Repantis, D., Schlattmann, P., Laisney, O., & Heuser, I. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.04.002 · Cited by 576
Eagle, D. M., Bari, A., & Robbins, T. W. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1127-6 · Cited by 548
Metadata
- Authors
- Minzenberg, M. J., & Carter, C. S.
- Affiliations
- University of California Davis Medical Center (US)
- Corresponding author
- Minzenberg, Michael J
- Venue
- Neuropsychopharmacology
- Published
- 2007-08-22
- Volume
- 33
- Issue
- 7
- Pages
- 1477-1502
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2122011624
- Semantic Scholar
- cf5b2a15296e7832bcfdd965f28583772ef2999c
- Cited by
- 713
- References
- 215
- Citations by year
- 2026: 18 · 2025: 32 · 2024: 25 · 2023: 33 · 2022: 33 · 2021: 46 · 2020: 26 · 2019: 19 · 2018: 33 · 2017: 42 · 2016: 22 · 2015: 49 · 2014: 48 · 2013: 62 · 2012: 59
- FWCI
- 3.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (MH 59883, MH066629, R01MH059883, R01MH066629)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Social Sciences › Arts and Humanities › Philosophy › Neuroethics, Human Enhancement, Biomedical Innovations
- Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
- Keywords
- modafinil, wakefulness-promoting agents, neurochemical mechanisms, cognition, catecholamines, serotonin, glutamate, GABA, orexin, histamine, working memory, episodic memory, prefrontal cortex, cognitive control, treatment-resistant depression, attention deficit hyperactivity disorder, schizophrenia, cognitive impairment, pharmacokinetics, abuse liability
- MeSH terms
- Modafinil, Animals, Mental Disorders, Benzhydryl Compounds, Brain Chemistry, Cognition, Humans, Neuroprotective Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.